BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 22, 2009
View Archived Issues
Liposomal influenza M2e vaccine shows efficacy in immunosuppressed mice
Read More
Exebryl-1 shows promise as a disease-modifying drug for the treatment of Alzheimer's disease
Read More
Differenting Alzheimer's disease and Lewy bodies dementia with ioflupane (I123) SPECT
Read More
Provectus initiates phase II PH-10 trial with new dosing regimen in psoriasis
Read More
Tekturna HCT approved in patients likely to need multiple blood pressure drugs
Read More
Vernalis selects new oncology development candidate, V-158411
Read More
FDA grants fast track status for apaziquone for bladder cancer
Read More
Swissmedic grants marketing authorization to Debiopharm for Moapar
Read More
Idenix completes proof-of-concept study for IDX-184 in hepatitis C virus
Read More
Oramed reports results from phase I oral insulin capsule study in type 1 diabetes
Read More
R-Tech Ueno completes phase I RK-023 study
Read More
Roche describes novel BLT receptor antagonists for the treatment of asthma, COPD
Read More
Wyeth patents novel K(V) potassium channel blockers
Read More
Sterix patent claims 17beta-HSD3 inhibitors
Read More
GlaxoSmithKline discovers novel P2X7 receptor antagonists
Read More
Preclinical data lead MABT-5102-A into clinical evaluation
Read More
BioCancell receives Israeli approval to initiate a phase I/IIa clinical trial of BC-819
Read More
Putative biomarkers not affected by semagacestat or solanezumab in AD patients
Read More
Wyeth stockholders approve adoption of merger agreement with Pfizer
Read More
MediciNova to initiate development of MN-221 for treatment of COPD exacerbations
Read More
MacroGenics initiates phase II PARADIGM clinical trial of MGAWN-1 for West Nile virus
Read More
Forma and LLS form partnership to develop novel blood cancer therapeutics
Read More
Health Canada approves Stem Cell's modified REGENESIS phase IIb trial of NTx-265
Read More
Archemix and Dicerna sign agreement for designing aptamer-DsiRNA therapeutics
Read More
Chugai files NDA in Japan for R-744 for renal anemia
Read More